Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Spin-Off Invesco ETF (NY: CSD )

80.07 +0.72 (+0.91%)
Official Closing Price Updated: 8:00 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,751
Open 79.77
Bid (Size) 75.54 (2)
Ask (Size) 84.66 (2)
Prev. Close 79.35
Today's Range 79.55 - 80.19
52wk Range 52.14 - 80.19
Shares Outstanding 7,900
Dividend Yield 0.56%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GE Vernova's Gas Power Services Underappreciated & Poised For Growth: Analyst
GE Vernova upgraded to Buy by BofA Securities, price target raised from $200 to $300. Analyst sees potential in Gas Power Services. 
Via Benzinga
GXO Logistics Q2: Revenue Gains Offset By Profit Margin Squeeze
GXO Logistics beats revenue consensus with $2.85B in Q2. Organic revenue rose 2%, new business wins add $270M. FY24 outlook reaffirmed. 
Via Benzinga

Performance

YTD
+25.72%
+25.72%
1 Month
+8.48%
+8.48%
3 Month
+14.99%
+14.99%
6 Month
+15.27%
+15.27%
1 Year
+44.59%
+44.59%

More News

Read More
GE HealthCare Taps AWS for Groundbreaking AI Medical Solutions: Details
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
What's Going On With GE Vernova Shares Today?
Via Benzinga
GXO Logistics Deploys Robotics Solution For Sporting Goods Retailer In France
Via Benzinga
Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse
Via InvestorPlace
Topics ETFs
Why Carrier Global Shares Are Surging Today
Via Benzinga
Why Apartment Income REIT Shares Are Rocketing Today
Via Benzinga
Radiopharmaceuticals Startup RayzeBio Seeks Public Debut After Raising $400M From Investors
Via Benzinga
Healthcare Software Firm Waystar Goes IPO Way With Potential $8B Valuation
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Second Time Charm: Sagimet Biosciences Seeks Public Debut With $75M IPO
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.